AI-driven clinical tools will remove diagnostic subjectivity, says Dr. Jitendra Singh
New Delhi, Feb 21 - At "Medllumina 2026: International Multi Specialty Medical Conference," Union Minister of State (Independent Charge) for Science and Technology Dr. Jitendra Singh said AI is set to strip subjectivity from diagnosis and make treatment more precise and patient-specific.
His stance was clear: AI won't replace doctors. It will sharpen clinical judgement, reduce misses, and help teams act faster with evidence at hand.
From judgement-heavy calls to data-backed decisions
Traditional diagnosis leans heavily on personal experience. That leaves room for variation and error, especially under time pressure.
Dr. Singh highlighted a simple example: a pathologist might miss a tiny cluster of malignant cells on a slide. An AI system can flag the exact region of interest, elevating sensitivity without slowing the workflow.
Where AI is already useful
- Pathology: Heatmaps that highlight atypia, quantify IHC, and assist mitotic counts on whole-slide images.
- Radiology: Triage for pneumothorax on chest X-rays or intracranial hemorrhage on CT to speed up critical reads.
- Genomics and molecular diagnostics: Variant prioritization and quality checks to support tumor boards.
- Clinical exams and EHRs: Automated review that surfaces red flags across labs, meds, vitals, and notes.
The goal is consistent: fewer oversights, faster signal detection, and clearer treatment paths.
Interdisciplinary by default
Dr. Singh underscored that medicine has moved beyond silos. With super-specialisation, collaboration with engineering and data science is now part of standard care.
Conferences that bring clinicians, lab scientists, engineers, and data teams together will set the pace for what's safe, useful, and scalable.
Context for India: shifting disease patterns
Conditions once clustered by region-diabetes in the south, thyroid issues in Himalayan belts-are now common nationwide. Lifestyle shifts and narrowing rural-urban gaps are pushing chronic disease risk everywhere.
AI can help manage caseloads and standardise quality across settings, from metros to district hospitals.
How to adopt AI tools safely in your hospital
- Start with one high-impact use case (e.g., pathology triage or chest X-ray prioritisation) and define success metrics upfront.
- Demand clinical validation in a population like yours; review sensitivity, specificity, AUROC, and calibration.
- Run local silent trials before go-live; compare model outputs with gold-standard reads.
- Check bias: stratify performance by age, sex, comorbidities, device type, and site.
- Insist on explainability artifacts (heatmaps, feature attributions) to support clinician trust.
- Integrate into existing workflow and PACS/LIS/EHR; avoid tool hopping.
- Set governance: named clinical owners, an M&M-style AI review, and change-control for model updates.
- Cover privacy, consent, and cybersecurity. Log every inference tied to a user and versioned model.
- Measure outcomes post-deployment: turnaround time, detection rates, downstream interventions, and patient outcomes.
- Keep the clinician as final decision-maker. Document overrides and learn from them.
Training the team
Upskill the people who will use and oversee these tools. Clinicians need to read model reports and know when to trust-or challenge-the output.
For a broader view of clinical AI use cases and implementation, see AI for Healthcare. Lab and molecular teams exploring AI-assisted pathology or genomics may find the AI Learning Path for Biochemists useful.
Guardrails and standards
Adopt solutions that align with recognised guidance and regulatory direction. This reduces risk and speeds internal approval.
Helpful references: WHO guidance on AI for health and the FDA's overview of AI/ML-enabled medical devices.
What to keep in focus
- AI reduces subjectivity and highlights what matters; it doesn't replace clinical judgement.
- Real value shows up in fewer misses, faster triage, and clearer next steps for patients.
- Interdisciplinary teams make these tools safe, useful, and accountable.
- Governance, validation, and continuous monitoring are non-negotiable.
As Dr. Singh noted, the tools have matured from bedside heuristics to imaging, molecular diagnostics, and now AI-assisted decisions. The work ahead is practical: pick the right problems, prove safety and benefit, and build trust where care happens-at the point of decision.
Your membership also unlocks:
